Yufeng Shang Department of Hematology Zhongnan Hospital of Wuhan University Biography Publications Institution JoVE Articles Yufeng Shang has not added a biography. If you are Yufeng Shang and would like to personalize this page please email our Author Liaison for assistance. Publications Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China Frontiers in Oncology. 2022 | Pubmed ID: 35372017 Evaluation of Prognostic Staging Systems of Multiple Myeloma in the Era of Novel Agents Hematological Oncology. Apr, 2022 | Pubmed ID: 34860428 Public Screening for COVID-19 in Wuhan, China and Beware of the Antibody Positive in Women and Tumor Patients Journal of Medical Virology. 04, 2022 | Pubmed ID: 34850404 Therapeutic Plateletpheresis in Patients With Thrombocytosis: Gender, Hemoglobin Before Apheresis Significantly Affect Collection Efficiency Frontiers in Medicine. 2021 | Pubmed ID: 35004735 Biological Characteristics of Umbilical Cord Mesenchymal Stem Cells and Its Therapeutic Potential for Hematological Disorders Frontiers in Cell and Developmental Biology. 2021 | Pubmed ID: 34012958 Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus Frontiers in Immunology. 2021 | Pubmed ID: 33936026 Factors Affecting Antibody Response to SARS-CoV-2 in Patients with Severe COVID-19 Journal of Medical Virology. 02, 2021 | Pubmed ID: 33289107 Novel Biomarkers for the Prediction of COVID-19 Progression a Retrospective, Multi-center Cohort Study Virulence. 12, 2020 | Pubmed ID: 33172355 Scoring Systems for Predicting Mortality for Severe Patients with COVID-19 EClinicalMedicine. Jul, 2020 | Pubmed ID: 32766541 TGF-β Receptor Inhibitor LY2109761 Enhances the Radiosensitivity of Gastric Cancer by Inactivating the TGF-β/SMAD4 Signaling Pathway Aging. 10, 2019 | Pubmed ID: 31631064 Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer Frontiers in Oncology. 2019 | Pubmed ID: 31616632 التألق بين الأطوار في الموقع تهجين مسحات نخاع العظم من المايلوما المتعددة Yalan Yu*1, Hui Shen*1, Li Liu1, Ping Luo1, Sanyun Wu1, Jing He1,2, Xiqin Tong1, Yufeng Shang1, Liang Shao1, Fuling Zhou1 1Department of Hematology, Zhongnan Hospital of Wuhan University, 2Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology JoVE 63083 Medicina
التألق بين الأطوار في الموقع تهجين مسحات نخاع العظم من المايلوما المتعددة Yalan Yu*1, Hui Shen*1, Li Liu1, Ping Luo1, Sanyun Wu1, Jing He1,2, Xiqin Tong1, Yufeng Shang1, Liang Shao1, Fuling Zhou1 1Department of Hematology, Zhongnan Hospital of Wuhan University, 2Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology JoVE 63083 Medicina